Related references
Note: Only part of the references are listed.Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study
Jeffrey D. Klausner et al.
CLINICAL INFECTIOUS DISEASES (2021)
Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial
Jonathan D. C. Ross et al.
LANCET (2019)
Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial
Marcus Y. Chen et al.
LANCET INFECTIOUS DISEASES (2019)
Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation
Stephanie N. Taylor et al.
CLINICAL INFECTIOUS DISEASES (2018)
Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin
David M. Whiley et al.
LANCET INFECTIOUS DISEASES (2018)
Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea
Stephanie N. Taylor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action
Teodora Wi et al.
PLOS MEDICINE (2017)
Genomic Epidemiology of Gonococcal Resistance to Extended-Spectrum Cephalosporins, Macrolides, and Fluoroquinolones in the United States, 2000-2013
Yonatan H. Grad et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Point-of-care antibiotic susceptibility testing for gonorrhoea: improving therapeutic options and sparing the use of cephalosporins
S. T. Sadiq et al.
SEXUALLY TRANSMITTED INFECTIONS (2010)
Share Paper
